Phase 1 Prematurity Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage
Intraventricular Hemorrhage of Prematurity
Johns Hopkins University60 enrolled2 locationsNCT05617833
Recruiting
Phase 1
Pharmacokinetics and Placental Transfer of Caffeine
Apnea of PrematurityPremature BirthBronchopulmonary Dysplasia+2 more
Indiana University30 enrolled1 locationNCT07570121
Recruiting
Phase 1
Safety, PK and PD of FLQ-101 in Premature Neonates
Retinopathy of Prematurity (ROP)
FELIQS INC.18 enrolled1 locationNCT07093255
Recruiting
Phase 1
Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants
Retinopathy of Prematurity
Region Skane15 enrolled2 locationsNCT05387941